Most therapeutic peptides are drugs, most of the popular ones are unauthorized, and selling or importing them is illegal
This manifests as hepatic injury and inflammation in the liver and can range from simple steatosis to metabolic dysfunction-associated steatohepatitis (MASH), also known as nonalcoholic steatohepatitis (NASH) (172, 173)
A longer-term initiative, the BALANCE (Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth) Model , will launch in Medicaid as early as May 2026 and in Medicare Part D by January 2027, combining GLP-1 access with evidence-based lifestyle supports ( [68] )
Discontinuation rates: who actually stays on treatment
GLP-1 NAION Lawsuit MDL 3163 Case Management Orders (CMOs) Below is the chronological log of Case Management Orders (CMOs) and foundational legal filings entered in MDL 3163: In Re: GLP-1 Receptor Agonists NAION Products Liability Litigation
Our team offers comprehensive consultations to assess your suitability for semaglutide